Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma
Author:
Funder
National Science and Technology Major Project
National Natural Science Funds for Distinguished Young Scholar of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference114 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J. Clin.,2018
2. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region;Zhu;Gut Liver,2016
3. Hepatocellular carcinoma;Forner;Lancet,2018
4. Molecular therapies and precision medicine for hepatocellular carcinoma;Llovet;Nat. Rev. Clin. Oncol.,2018
5. Cancer statistics, 2019;Siegel;Ca - Cancer J. Clin.,2019
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolic vulnerabilities in cancer: A new therapeutic strategy;Critical Reviews in Oncology/Hematology;2024-09
2. Inhibition of KIF20A enhances the immunotherapeutic effect of hepatocellular carcinoma by enhancing c-Myc ubiquitination;Cancer Letters;2024-08
3. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway;Molecular Medicine;2024-07-25
4. Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling;Cancer Letters;2024-06
5. Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges;Cancers;2024-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3